Understanding Crohn's Disease

CROHN'S IN NUMBERS

780,000 Americans are living with Crohn's disease. Age 15–35 is the most common age of diagnosis, though any age is possible. Risk is 2–3x higher if a first-degree relative has IBD. Up to 70% of patients achieve remission with modern biologics.

CROHN'S VS. ULCERATIVE COLITIS

Crohn's and ulcerative colitis (UC) are the two main forms of inflammatory bowel disease (IBD). Crohn's can affect any part of the GI tract from mouth to rectum — inflammation is patchy and extends through all layers of the bowel wall ("transmural"). UC affects only the colon and rectum, with inflammation confined to the inner lining.

WHAT CAUSES CROHN'S DISEASE?

Crohn's results from a complex interplay between genetics, the immune system, the gut microbiome, and environmental triggers. The immune system mistakenly attacks the lining of the GI tract, producing chronic inflammation that damages the bowel wall over time, leading to ulcers, scarring, and structural changes.

Key risk factors: family history of IBD, smoking (significantly worsens Crohn's), living in industrialized Western countries, diet low in fiber and high in processed food, and early antibiotic use affecting the developing gut microbiome. Stress doesn't cause Crohn's, but can trigger flares.

SYMPTOMS

Persistent diarrhea, abdominal pain and cramping, blood in the stool, fatigue and low energy, unintentional weight loss, fever during flares, reduced appetite or nausea, and urgent need to use the bathroom.

Seek urgent care for: severe abdominal pain, high fever, significant rectal bleeding, signs of bowel obstruction (persistent vomiting, inability to pass stool or gas), or sudden dramatic worsening of symptoms.

EXTRA-INTESTINAL MANIFESTATIONS

Up to 40% of people with Crohn's experience symptoms outside the GI tract:

• Joints: Arthritis affecting large joints or the spine (ankylosing spondylitis)
• Eyes: Uveitis and episcleritis causing redness, pain, and light sensitivity
• Skin: Erythema nodosum and pyoderma gangrenosum
• Liver: Primary sclerosing cholangitis (PSC) in a subset of patients
• Bones: Elevated osteoporosis risk from chronic inflammation and malabsorption
• Blood: Anemia from blood loss, iron deficiency, or vitamin B12/folate malabsorption

COMPLICATIONS

Strictures — bowel narrowing from scar tissue, can cause obstruction. Fistulas — abnormal tunnels between loops of bowel or between the bowel and bladder, skin, or vagina (a hallmark of Crohn's). Abscesses — pockets of infection near the bowel or anus. Perianal disease affects up to 35% of people with Crohn's. Long-standing Crohn's colitis elevates colorectal cancer risk, requiring regular colonoscopy surveillance.

DIAGNOSIS

No single test for Crohn's — diagnosis combines symptoms, blood/stool tests, imaging, and endoscopy:

1. Blood and stool tests — anemia, CRP/ESR, fecal calprotectin (distinguishes IBD from IBS)
2. Colonoscopy with biopsy — gold standard; examines colon and terminal ileum with tissue biopsies
3. MRI and CT enterography — cross-sectional imaging for small intestine disease, strictures, fistulas, abscesses
4. Capsule endoscopy — pill camera that photographs the entire small intestine

TREATMENT

The modern goal is mucosal healing — restoring the bowel lining to a healthy state — not just symptom relief.

1. Corticosteroids (prednisone, budesonide) — Effective for inducing remission during flares but not suitable long-term. Used as a bridge to maintenance therapy.

2. Immunomodulators (azathioprine, 6-MP, methotrexate) — Suppress immune response; take 3–6 months to reach full effect. Often combined with biologics.

3. Anti-TNF biologics (infliximab/Remicade, adalimumab/Humira) — First biologics approved for Crohn's; block TNF, a key driver of inflammation. Transformed outcomes for moderate-to-severe disease.

4. Newer biologics and small molecules — Vedolizumab (gut-selective), ustekinumab (IL-12/23), risankizumab (IL-23), and JAK inhibitors like upadacitinib (oral dosing) offer effective alternatives.

5. Surgery — Doesn't cure Crohn's, but ~50% of patients need it within 10 years to manage strictures, abscesses, or severely damaged bowel segments.

Treat-to-target approach: Regularly monitor objective inflammation markers and adjust therapy until mucosal healing is confirmed, even if symptoms improve.

LIVING WELL WITH CROHN'S

Find food triggers — keep a food diary during flares; a low-residue diet during active disease helps. Stop smoking — doubles flare risk and surgery likelihood; the single most impactful lifestyle change. Stay active — moderate exercise reduces inflammation and improves mood and bone density. Regular monitoring with a gastroenterologist is essential — Crohn's can be active without obvious symptoms.

Anxiety and depression are 2–3x more common in people with Crohn's than the general population. Mental health support is a legitimate and important part of comprehensive Crohn's care.